These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of infections due to methicillin-resistant Staphylococcus aureus. Watanakunakorn C. Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635 [Abstract] [Full Text] [Related]
6. Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Rodríguez A, Vicente MV, Olay T. Eur J Clin Microbiol; 1985 Dec; 4(6):603-5. PubMed ID: 3853984 [No Abstract] [Full Text] [Related]
7. Therapeutic considerations for infections caused by Staphylococcus epidermidis. Rodvold KA. Pharmacotherapy; 1988 Dec; 8(6 Pt 2):14S-18S. PubMed ID: 3075743 [Abstract] [Full Text] [Related]
10. Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection. Eng RH, Smith SM, Tillem M, Cherubin C. Arch Intern Med; 1985 Jan; 145(1):146-8. PubMed ID: 3844314 [Abstract] [Full Text] [Related]
16. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR. Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776 [Abstract] [Full Text] [Related]
17. Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. Dworkin R, Modin G, Kunz S, Rich R, Zak O, Sande M. Antimicrob Agents Chemother; 1990 Jun; 34(6):1014-6. PubMed ID: 2393259 [Abstract] [Full Text] [Related]